Sunday, June 13, 2021
Home Tags CDSCO

Tag: CDSCO

Black Fungus: Mankind Pharma launches drug for treatment

Mankind Pharma on Thursday said it has launched Posaconazole Gastro resistant tablets, used to treat black fungus, in the country. The company has launched...

IPC to roll out various training Programmes for stake holders

The Indian Pharmacopoeia Commission (IPC) which is the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (NCC-PvPI), will be rolling...

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...

Govt caps prices of Oxygen Concentrators

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has capped the trade margin for oxygen concentrators at 70 per cent, the Ministry of Chemicals and Fertilizers...

Drug alert: 23 out of 931 samples declared as NSQ in...

The Central Drugs Standard Control Organisation (CDSCO) in its monthly surveillance report pan-India has declared 908 as standard quality (SQ) based on...

Revolution in Diagnostics industry with new age technology

HealthCube, a combination of smart diagnostics and artificial intelligence, is planning to bring about a major transformation in the Indian healthcare ecosystem...

DCGI issues safety alerts on Medical Devices

The Drugs Controller General of India (DCGI) has issued safety alerts on medical devices related to orthopaedic, neurosurgery and eye related disorders...

Baricitinib: BDR Pharma signs licensing agreement with Lilly

BDR Pharma has entered into a royalty-free, limited and non-exclusive voluntary licensing agreement with Eli Lilly and Company, for the manufacturing and...

DTAB dismisses proposal on labeling of drugs non-vegetarian origin with red...

The Drugs Technical Advisory Board (DTAB) has dismissed a proposal regarding labeling of drugs containing components of non-vegetarian origin with a red...

Govt to rectify Form CT-03 under the New Drugs and Clinical...

The Union health ministry will soon rectify Form CT-03 under the New Drugs and Clinical Trials (NDCT) Rules, 2019 to include Department...

IPC and CDSCO meet to outline plan for designing Pharmacovigilance cell

Experts at Indian Pharmacopoeia Commission (IPC) and Central Drugs Standard Control Organisation (CDSCO) recently met to outline a plan towards designing Pharmacovigilance...

CDSCO to remove 8 redundant compliances related to D&C Rules, MD...

To reduce and rationalize compliance burden for improving cost and ease of doing business, the Central Drugs Standard Control Organisation (CDSCO) will...

Govt to include psoriasis drug acitretin in Schedule H

The Union health ministry will soon include psoriasis drug “Acitretin” in the Schedule H of the Drugs Rules, 1945 to prevent adverse...

Govt to amend Rule 87 of Medical Devices Rule 2017

The Union health ministry will soon amend provisions of sale of notified medical devices as per Medical Device Rules (MDR)-2017 to effectively...

NATCO applies to CDSCO for EUA of Molnupiravir capsules

Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir...

IPC starts verifying testing protocols for DCGI approved drugs

The Indian Pharmacopoeia Commission (IPC) has started verifying the testing protocols for Drugs Controller General of India (DCGI) approved drugs recently introduced...

Drug alert: 18 out of 1571 samples declared as NSQ in...

The Central Drugs Standard Control Organisation (CDSCO) has declared 1,553 as standard quality (SQ) based on testing done on 1,571 samples in...

Govt notifies Govt Analyst for all classes of drugs as per...

The Union health ministry has notified one government analyst in respect of all classes of drugs at Central Drugs Testing Laboratory (CDTL),...

Government allocates supply of Remdesivir to 19 States, UTs

Various steps have been taken by Government of India to address the emerging issues for effective management of the recent unprecendented spike...

Import of drugs with residual shelf life: deadline extended till October...

The Drugs Controller General of India (DCGI) has extended the deadline till October 31, 2021 for allowing import of drugs with residual...

Latest Circulars, Notices & Guidelines: CDSCO, DCGI

Circulars – CDSCO, DCGI Govt of India, DCGI, Health Ministry, ICMR issues notices / circulars time to time for...

Safe Medical Devices: 1,257 reports evaluated through reporting tools at IPC

The Materiovigilance Programme of India (MvPI) has in total received and evaluated 1,257 Medical Devices Adverse Events (MDAE) reports till date through...

DCGI extends deadline to submit documents for Import & Regn. of...

As the situation arising out of the C-19 pandemic is worsening further in the country, the Drugs Controller General of India (DCGI)...

Type 2 Diabetes के लिए आएगी नई दवा, कम्पनी ने CDSCO...

नई दिल्ली. मैनकाइंड फार्मा कंपनी (Mankind Pharma) के लिए भारतीय औषधि नियामक प्राधिकरण (Indian Drug Regulatory Authority), केंद्रीय औषधि मानक नियंत्रण संगठन (CDSCO) की मंजूरी पाने...

Latest posts

C-19: बच्चों का संक्रमण से कैसे करें बचाव: Lets Know

C-19 की पहली लहर ने बुजुर्गों को ज़्यादा प्रभावित किया था और इसकी दूसरी लहर ने युवाओं को. इससे अब यह अन्दाजा...

Authors

30 POSTS0 COMMENTS
23 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS